Jennifer Hooton is a Drug Product Project Lead at Novartis, based in Basel, Switzerland. She specializes in developing solid oral dosage forms for early and late phase development as well as the introduction of data science and modeling into drug product development. Jennifer qualified as pharmacist in 2000 and completed her PhD studies at the University of Nottingham in 2003. Prior to Novartis, she worked as a material scientist for AstraZeneca in Macclesfield, UK. She has over 15 years of experience in drug product development and is interested in understanding how drug and excipient properties can impact formulation development.